Økernveien 94
Oslo 0579
Norway
47 23 05 96 60
https://www.medistim.com
Settore/i:
Settore:
Impiegati a tempo pieno: 150
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Ms. Kari Eian Krogstad | CEO & President | 4,41M | N/D | 1964 |
Mr. Thomas Jakobsen | Chief Financial Officer | 2,59M | N/D | 1969 |
Mr. Helge Borslid | Vice President of Operations & Manufacturing | 1,67M | N/D | N/D |
Ms. Hæge Johanne Krogh Wetterhus | Vice President of Marketing | 1,84M | N/D | 1964 |
Mr. Hakon Grothe | Chief Innovation Officer | 1,77M | N/D | N/D |
Mr. Ole Arne Eiksund | Chief Business Development Officer | 1,68M | N/D | 1967 |
Mr. Mike Farbelow | President of Medistim USA Inc | 3,63M | N/D | N/D |
Mr. Roger Reino Morberg | Vice President of Sales - APAC | 2,42M | N/D | 1964 |
Ms. Stephanie D'Avout Stenhagen | Vice President of Sales EMEA | 1,69M | N/D | N/D |
Mr. Ole Jorgen Robsrud | Managing Director of Medistim Norge AS | 1,78M | N/D | N/D |
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
L'ISS Governance QualityScore di Medistim ASA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.